Fitness tracker maker Skulpt picks up $4.1 mln Series A

Fitness tracker maker Skulpt has raised $4.1 million in Series A funding. Nautilus Venture Partners led the round with participation from Caerus Venture Partners.


New York — Skulpt, a leading technology developer recognized for the first fitness device to accurately measure muscle quality and body fat percentage, today announced the closing of a $4.1M Series A funding round. Nautilus Venture Partners led the round with additional participation from Caerus Venture Partners who led their $1.6M Seed Round in 2014. The new financing will be used for expansion into retail for 2016 and to enhance Skulpt’s mobile app functionality including personalized, data-driven fitness plans.

Last week, Skulpt debuted the Chisel, their next generation product at CES Unveiled in New York, winning the CES 2016 Innovations Award, an annual competition honoring outstanding design and engineering in consumer technology products. Skulpt’s success continues today as the winners of the “Best of What’s New” award from Popular Science in the health category.

Jose Bohorquez, the co-founder and CEO of Skulpt said, “I’m really proud of what our team has accomplished so far and this round of funding helps us take things to the next level. We plan to expand into retail in 2016 and grow our team to continuously improve our app for current and future customers. Our vision is to help people improve their health and fitness efficiently, by using information about their bodies that they can’t get anywhere else.”

Along with this round of funding, Skulpt launched the Chisel via an Indiegogo campaign last week. Juan Jaramillo, VP of Product for Skulpt, said “The Indiegogo community put us on the map two years ago when we launched our first product, the Skulpt Aim. We wanted to give them an opportunity to order the Chisel before it’s available to anyone else, and provide us with valuable feedback that will help us make the overall product even better.”

Launched in July 2009, Skulpt leverages technology developed by co-founder Dr. Seward Rutkove of Harvard Medical School to help consumers improve their health and fitness.

Brian Kang, Managing Partner at Nautilus Venture Partners, the lead investor in the round said, “The thing that interests us most about Skulpt is how unique and impactful the technology is, especially compared to other devices on the market. Their team has a scientific approach to fitness tracking that will keep them well ahead of the competition with the potential to truly redefine this space.”

Thanks to Skulpt, for the first time, users are able to gather data about the quality of individual muscles to better understand their bodies and succeed in fitness training.

Skulpt’s EIM technology was developed at Harvard and MIT and is currently used in top research hospitals across the US.

“We recognized long ago that there were no good ways to measure muscle health, so Dr. Rutkove and I embarked on a mission to find a better way to measure muscles over 13 years ago, which led to the development of Electrical Impedance Myography. After EIM was successfully adopted by the medical space, we saw the great potential of introducing it to fitness enthusiasts. Our mission continues to help anyone trying to maintain or improve their health and fitness,” added Bohorquez.

For more information about Skulpt’s features and functionality, please visit

About Skulpt

Skulpt develops technology to empower users to better understand their bodies and achieve their fitness goals. Skulpt’s proprietary technology is the world’s first to measure the muscle quality of individual muscles, and measure body fat percentage more accurately and conveniently than other tools on the market. Skulpt revolutionizes the fitness industry through data driven fitness, providing users with more information about their bodies than previously available.

Initially developed for the medical space, Skulpt’s technology is based on over a decade of research at Harvard and MIT. It has been used in top US research hospitals, validated through dozens of clinical trials, and has even been used in collaboration with NASA.

For more information visit:

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!